Marek Trněný, MD

Dept. chair
First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic, Czech Republic

n/a

Poster(s):

• 2010 - Zanubrutinib vs bendamustine + rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma: extended follow-up of the SEQUOIA study